# VivaVision Biotech, Inc.: Pharmaceuticals, China > VivaVision Biotech, Inc.: VivaVision Biotech, Inc. Based in China. Founded 2016. What Millionrounds holds on them, and what we have not seen. Source: https://millionrounds.com/startup/vivavision-biotech-inc (Millionrounds; every figure on the page links to its filing or article) China · [Pharmaceuticals startup](https://millionrounds.com/companies) # VivaVision Biotech, Inc. VivaVision Biotech, Inc. Email Funding reported Last round: Series D Pharmaceuticals China Follow VivaVision Biotech, Inc. and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fvivavision-biotech-inc) Company summary - **Founded:** 2016 10 years old - **Team:** 6 1 to 10 people - **Funding reported:** 431M as listed, currency not stated - **Last round:** Series D May 2023 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for VivaVision Biotech, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About VivaVision Biotech, Inc. VivaVision Biotech, Inc. is a clinical-stage pharmaceutical company based in China, founded in 2016. The company focuses on developing innovative therapies for ocular diseases, particularly chronic eye conditions and other ophthalmic disorders. Its core business revolves around research and development, aiming to create best-in-class and first-in-class therapies to address unmet needs in both anterior and posterior segment eye diseases. VivaVision's pipeline includes several investigational therapies, such as VVN001 for dry eye disease, VVN539 for glaucoma, and VVN461 for non-infectious ocular inflammation and uveitis. The company is dedicated to advancing treatments for patients suffering from various ocular conditions, including dry eye, glaucoma, and retinal diseases. ## What company datasets say VivaVision Biotech, Inc. raised Funding, as reported Reported in all **431M** in the source's currency Rounds **5** Last round **Series D** Last round size **46M** Last round date **May 2023** Investors listed **19** ## On a portfolio page Investors who name them - [Xiamen Changrong Investment Management](https://millionrounds.com/fund/xiamen-changrong-investment-management) Each firm lists VivaVision Biotech, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for health care medical innovation eye health therapies eye care therapies medical research clinical-stage pharmaceutical biotech ophthalmology vision health pharmaceutical clinical research hospital & health care research and development medical biotech company investigational drugs eye disease research Built with from their website Apache Microsoft Exchange Microsoft 365 Apps & Services Microsoft Exchange Online Microsoft 365 Apache HTTP Server Outlook Alibaba Cloud Microsoft Email Providers - **Sector:** Pharmaceuticals - **Industry code:** NAICS 541714, 325414, SIC 2834, 8731 - **Region:** Shang Hai Shi - **Revenue:** 3.1M a year, as listed - **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/vivavision-biotech) ## Pharmaceuticals in China Startups like it - [**InventisBio** Shanghai · founded 2013 *Raised*](https://millionrounds.com/company/inventisbio) - [**Alpha Biopharma** Shanghai · founded 2017 *Raised*](https://millionrounds.com/company/alpha-biopharma) - [**IMPACT Therapeutics** founded 2009 *Raised*](https://millionrounds.com/company/impact-therapeutics) - [**Laviana** Taizhou · founded 2003 *Raised*](https://millionrounds.com/company/laviana) - [**Naxions** Beijing · founded 2015 *Raised*](https://millionrounds.com/company/naxions) - [**Shanghai Cell Therapy Group** founded 2013](https://millionrounds.com/startup/shanghai-cell-therapy-group) - [**Sinotau** founded 2005](https://millionrounds.com/startup/sinotau) - [**Huisheng Biopharmaceutical Co., Ltd** founded 2014](https://millionrounds.com/startup/huisheng-biopharmaceutical-co-ltd) ## Is this your company? Add your raise, your deck and your story, and put VivaVision Biotech, Inc. in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)